I agree that this site is using cookies. You can find further informations here.
X
Borg, Christophe
588  results:
Search for persons X
?
1

Evaluation of immune infiltrate according to the HER2 statu..:

Molimard, Chloé ; Dor, Fanny ; Overs, Alexis...
Digestive and Liver Disease.  56 (2024)  5 - p. 853-860 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Visceral fat and clinical outcome in patients receiving fir..:

Cazeneuve, Nicolas ; Bouché, Olivier ; Leger, Julie...
Clinics and Research in Hepatology and Gastroenterology.  48 (2024)  7 - p. 102380 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Prognostic value of the tumor-to-liver density ratio in pat..:

Mazard, Thibault ; Mollevi, Caroline ; Loyer, Evelyne M....
Cancer Imaging.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
4

Atezolizumab plus modified docetaxel, cisplatin, and fluoro..:

Kim, Stefano ; Ghiringhelli, Francois ; de la Fouchardière, Christelle...
The Lancet Oncology.  25 (2024)  4 - p. 518-528 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Temporal and spatial heterogeneity of HER2 status in metast..:

D'Angelo, Flavia ; Monnien, Franck ; Overs, Alexis...
Diagnostic Pathology.  19 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
6

Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ..:

Botsen, Damien ; Chabaud, Sylvie ; Perrier, Hervé...
Digestive and Liver Disease.  , 2024
Link: https://doi.org/10.1016/..
 
?
7

Prognostic Factors for Long-Term Eribulin Response in a Coh..:

El Kaddissi, Antoine ; Vernerey, Dewi ; Falcoz, Antoine...
Clinical Breast Cancer.  , 2024
Link: https://doi.org/10.1016/..
 
?
8

First-line durvalumab and tremelimumab with chemotherapy in..:

Thibaudin, Marion ; Fumet, Jean-David ; Chibaudel, Benoist...
Nature Medicine.  29 (2023)  8 - p. 2087-2098 , 2023
Link: https://doi.org/10.1038/..
 
?
9

DCF versus doublet chemotherapy as first-line treatment of ..:

Kim, Stefano ; Vendrely, Véronique ; Saint, Angélique...
Experimental Hematology & Oncology.  12 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
10

Microfluidic device combining hydrodynamic and dielectropho..:

Lipp, Clémentine ; Koebel, Laure ; Loyon, Romain...
Lab on a Chip.  23 (2023)  16 - p. 3593-3602 , 2023
Link: https://doi.org/10.1039/..
 
?
11

CD8+ CD226high T cells in liver metastases dictate the prog..:

Viot, Julien ; Abdeljaoued, Syrine ; Vienot, Angélique...
Cellular & Molecular Immunology.  20 (2023)  4 - p. 365-378 , 2023
Link: https://doi.org/10.1038/..
 
?
12

Confounding mitigation for the exposure‐response relationsh..:

Lobet, Sarah ; Caulet, Morgane ; Paintaud, Gilles...
British Journal of Clinical Pharmacology.  90 (2023)  4 - p. 976-986 , 2023
Link: https://doi.org/10.1111/..
 
?
13

Predictive biomarkers and specific immune responses of COVI..:

Spehner, Laurie ; Orillard, Emeline ; Falcoz, Antoine...
BMJ Oncology.  2 (2023)  1 - p. e000054 , 2023
Link: https://doi.org/10.1136/..
 
?
14

Primary resistance to immunotherapy in patients with a dMMR..:

Flecchia, Clémence ; Auclin, Edouard ; Alouani, Emily...
British Journal of Cancer.  130 (2023)  3 - p. 442-449 , 2023
Link: https://doi.org/10.1038/..
 
?
15

Efficacy and safety of maintenance therapy with pamiparib v..:

Ciardiello, Fortunato ; Bang, Yung‐Jue ; Cervantes, Andrés...
Cancer Medicine.  12 (2023)  12 - p. 13145-13154 , 2023
Link: https://doi.org/10.1002/..
 
1-15